Daniel Bertholet
InvestorFounder & Managing Partner at 4see Ventures
Geneva
Writes $100K – $5M checks · typically $1.5M
About
Founder and Managing Partner of 4see ventures, established in Geneva in 2019, with over two decades in venture capital and growth equity. He began his VC career in 2003 at Reference Capital and Endeavour Vision, focusing on life sciences and medtech in Europe and the US, and holds an MBA with honours.
Experience
- 4see venturesManaging Partnercurrent2019 — presentGeneva Area, Switzerland
- HAYA Therapeutics SABoard Observercurrent2020 — presentLausanne, Vaud, Switzerland
- LumiThera, Inc.Board Member2020 — 2025Greater Seattle Area
- Endeavour VisionSr. Investment Director2007 — 2018Geneva Area, Switzerland
- IndependentBusiness Angel1996 — 2017Geneva, Switzerland
- GenevestInvestment Manager2003 — 2007Geneva Area, Switzerland
- Vision CapitalAnalyst2003Geneva Area, Switzerland
- eSecuriumCo-founder and CFO2000 — 2002Geneva Area, Switzerland
- Business Environment Risk Intelligence (BERI)Manager, Country Risk Assessment1995 — 1998Washington D.C. Metro Area
Education
- Swiss Board SchoolCertificat, Best Practices of Corporate Governance2019 — 2020
- Sciences PoMBA, Business management2000
- American UniversityMA, International Politics1992 — 1994
- University of GenevaBachelor's degree, Political Science and Government1989 — 1992
Skills & more
+12 more
Business StrategyCorporate DevelopmentMergers & AcquisitionsIPOCorporate FinanceFinancial ModelingEquitiesLife SciencesStrategyManagement ConsultingGrowth CapitalInvestment StrategiesLanguages English · French · German
From Daniel's professional profile.
Same school
Also attended Swiss Board School4
Also attended Sciences Po200
+ 194 more
Also attended American University71
+ 65 more
Also attended University of Geneva43
+ 37 more
Shared employers
Also worked at HAYA Therapeutics SA6
Also worked at Endeavour Vision7
+ 1 more
Deals · 9
DistalmotionSolo GP
via 4see Ventures
FenXSolo GP
via 4see Ventures
GoodwallSolo GP
via 4see Ventures
Haya TherapeuticsSolo GP
via 4see Ventures
TransmutexSolo GP
via 4see Ventures
CysecSolo GP
via 4see Ventures
NetGuardiansSolo GP
via 4see Ventures
Priothera Ltd.Solo GP
via 4see Ventures
StaliclaSolo GP
via 4see Ventures
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.































